A Randomized Phase II Trial of Nal-IRI and 5-Fluorouracil Compared to 5-Fluorouracil in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- Acronyms NALIRICC
- 01 Nov 2017 Status changed from not yet recruiting to recruiting.
- 16 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 1 Sep 2017.
- 15 Jun 2017 Planned End Date changed from 1 Apr 2021 to 1 Jul 2021.